Deep Bio Inc.
PrivateLast Round
Strategic
Oct 26, 2023
Est. Valuation
$49.52M
Total Funding Raised
$25.97M
Company Overview
Deep Bio Inc. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Strategic round in October 2023.
Deep Bio Inc. is a healthcare AI company that develops deep learning-based software to aid in cancer pathology diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Biotechnology, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deep Bio Inc. Comparables
Compare Deep Bio Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qritive | 88% | |
| Ibex Medical Analytics | 85% | |
| AIRA Matrix | 80% |
For institutional investors. Book with your work email.
Deep Bio Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Oct 26, 2023 | ||||
| Grant | Jul 7, 2023 | ||||
| Series B Extension | Jun 5, 2020 | ||||
| Series B | Mar 11, 2020 | ||||
| Series A | May 28, 2018 | ||||
Series A | Mar 2, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Deep Bio Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hyundai Investment Partners | Series A |
| Shinhan Venture Investment | Series B |
| Hyundai Venture Investment Corporation | Series A, Series B |
| Albatross Investment | Series B |
| Daesung Private Equity | Series A |
| ROI Investment Partners | Series A |
| G.N.Tech Venture Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 33% MoM.
- May 3, 2025
Monthly visitors grew 95% MoM, reaching 4.1K.
For institutional investors. Book with your work email.
Deep Bio Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deep Bio Inc.'s valuation, stock price, and market status.
Is Deep Bio Inc. a public or private company?
Deep Bio Inc. is a private company.
What is the current stock price of Deep Bio Inc.?
Deep Bio Inc. is a private company, so its shares have no public market price. Caplight tracks Deep Bio Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deep Bio Inc. worth (valuation)?
Deep Bio Inc.'s valuation is estimated at $49.5M based on funding round data.
Can I buy Deep Bio Inc. stock?
Deep Bio Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deep Bio Inc.'s last funding round?
Deep Bio Inc.'s most recent funding round was Strategic on October 26, 2023.
Who are the main investors in Deep Bio Inc.?
Key investors in Deep Bio Inc. include Hyundai Investment Partners, Shinhan Venture Investment, Hyundai Venture Investment Corporation, Albatross Investment, Daesung Private Equity.
Will Deep Bio Inc. IPO soon?
No public IPO plans have been announced for Deep Bio Inc..
How can I track Deep Bio Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Deep Bio Inc.'s shares on secondary markets.